Cillo, Vebencia M.

HRN: 00-48-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2023
METRONIDAZOLE 500MG (TAB)
09/17/2023
09/23/2023
PO
500MG
TID
Amoebiasis
Checking Final Appropriateness 
09/18/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/18/2023
09/25/2023
IV
500mg
Q8H
Intestinal Amoebiasis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: